Transition of amyloid/mutant p53 from tumor suppressor to an oncogene and therapeutic approaches to ameliorate metastasis and cancer stemness

S Sengupta, SM Ghufran, A Khan, S Biswas… - Cancer Cell …, 2022 - Springer
The tumor suppressor p53 when undergoes amyloid formation confers several gain-of-
function (GOF) activities that affect molecular pathways crucial for tumorigenesis and …

Oncogenic gain of function due to p53 amyloids occurs through aberrant alteration of cell cycle and proliferation

A Navalkar, A Paul, A Sakunthala… - Journal of cell …, 2022 - journals.biologists.com
Transcription factor p53 (also known as TP53) has been shown to aggregate into
cytoplasmic and nuclear inclusions, compromising its native tumor suppressive functions …

Cytoplasmic p53 aggregates accumulated in p53-mutated cancer correlate with poor prognosis

N Iwahashi, M Ikezaki, Y Komohara, Y Fujiwara… - PNAS …, 2022 - academic.oup.com
Recent studies suggested that aggregates of mutant p53 proteins may propagate and impair
normal p53 functioning in recipient cells. Our previous study showed that cancer cell-derived …

A novel cuproptosis-related subtypes and gene signature associates with immunophenotype and predicts prognosis accurately in neuroblastoma

XM Tian, B Xiang, YH Yu, Q Li, ZX Zhang… - Frontiers in …, 2022 - frontiersin.org
Background Neuroblastoma (NB) is the most frequent solid tumor in pediatrics, which
accounts for roughly 15% of cancer-related mortality in children. NB exhibited genetic …

p53 oligomerization status as an indicator of sensitivity of p53-wildtype neuroblastomas to the combination of DNA damaging agent and Chk1 inhibitor

AA Levesque, RM Pappalardo, P Puli, LA Enzor… - Plos one, 2022 - journals.plos.org
Neuroblastomas are one of the most common types of solid tumors in infants and children
and are responsible for approximately 15% of childhood cancer deaths. Neuroblastomas …

Identify non-mutational p53 functional deficiency in human cancers

Q Li, Y Zhang, S Luo, Z Zhang, AL Oberg, DE Kozono… - bioRxiv, 2022 - biorxiv.org
An accurate assessment of TP53's functional status is critical for cancer genomic medicine.
However, there is a significant challenge in identifying tumors with non-mutational p53 …

Heberferon distinctively targets cell cycle in the glioblastoma-derived cell line u-87mg

J Miranda, D Vázquez-Blomquist, R Bringas… - bioRxiv, 2022 - biorxiv.org
Background HeberFERON is a co-formulation of α2b and γ interferons, based on their
synergism, that have shown its clinical superiority over individual interferons in basal cell …

[PDF][PDF] EXTRACELLULAR VESICLE-DERIVED

RM Raymond - ourarchive.otago.ac.nz
Although an aging population has led to a growing socioeconomic burden of
neurodegenerative diseases such as Alzheimer's disease (AD), inadequate techniques for …